Global Anti-VEGF Injection Supply, Demand and Key Producers, 2024-2030
The global Anti-VEGF Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Anti-VEGF Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-VEGF Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-VEGF Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-VEGF Injection total production and demand, 2019-2030, (K Units)
Global Anti-VEGF Injection total production value, 2019-2030, (USD Million)
Global Anti-VEGF Injection production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Anti-VEGF Injection consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Anti-VEGF Injection domestic production, consumption, key domestic manufacturers and share
Global Anti-VEGF Injection production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Anti-VEGF Injection production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Anti-VEGF Injection production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Anti-VEGF Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Bayer, Genentech, Novartis, Coherus BioSciences Inc., Regeneron, Qilu Pharmaceutical Co.,Ltd., Innovent Biologics and Anke Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-VEGF Injection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Anti-VEGF Injection Market, By Region:
1. How big is the global Anti-VEGF Injection market?
2. What is the demand of the global Anti-VEGF Injection market?
3. What is the year over year growth of the global Anti-VEGF Injection market?
4. What is the production and production value of the global Anti-VEGF Injection market?
5. Who are the key producers in the global Anti-VEGF Injection market?
This report studies the global Anti-VEGF Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-VEGF Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-VEGF Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-VEGF Injection total production and demand, 2019-2030, (K Units)
Global Anti-VEGF Injection total production value, 2019-2030, (USD Million)
Global Anti-VEGF Injection production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Anti-VEGF Injection consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Anti-VEGF Injection domestic production, consumption, key domestic manufacturers and share
Global Anti-VEGF Injection production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Anti-VEGF Injection production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Anti-VEGF Injection production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Anti-VEGF Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Bayer, Genentech, Novartis, Coherus BioSciences Inc., Regeneron, Qilu Pharmaceutical Co.,Ltd., Innovent Biologics and Anke Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-VEGF Injection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Anti-VEGF Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Others
- Age-related Macular Degeneration (AMD)
- Diabetic Retinopathy
- Retinal Vein Occlusion (RVO)
- Retinopathy of Prematurity (ROP)
- Uveitis
- Neovascular Glaucoma
- Others
- Roche
- Bayer
- Genentech
- Novartis
- Coherus BioSciences Inc.
- Regeneron
- Qilu Pharmaceutical Co.,Ltd.
- Innovent Biologics
- Anke Biotechnology
- Shenzhen Kangzhe Pharmaceutical Co Ltd
- Chengdu Kanghong Pharmaceutical Group
1. How big is the global Anti-VEGF Injection market?
2. What is the demand of the global Anti-VEGF Injection market?
3. What is the year over year growth of the global Anti-VEGF Injection market?
4. What is the production and production value of the global Anti-VEGF Injection market?
5. Who are the key producers in the global Anti-VEGF Injection market?
1 SUPPLY SUMMARY
1.1 Anti-VEGF Injection Introduction
1.2 World Anti-VEGF Injection Supply & Forecast
1.2.1 World Anti-VEGF Injection Production Value (2019 & 2023 & 2030)
1.2.2 World Anti-VEGF Injection Production (2019-2030)
1.2.3 World Anti-VEGF Injection Pricing Trends (2019-2030)
1.3 World Anti-VEGF Injection Production by Region (Based on Production Site)
1.3.1 World Anti-VEGF Injection Production Value by Region (2019-2030)
1.3.2 World Anti-VEGF Injection Production by Region (2019-2030)
1.3.3 World Anti-VEGF Injection Average Price by Region (2019-2030)
1.3.4 North America Anti-VEGF Injection Production (2019-2030)
1.3.5 Europe Anti-VEGF Injection Production (2019-2030)
1.3.6 China Anti-VEGF Injection Production (2019-2030)
1.3.7 Japan Anti-VEGF Injection Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-VEGF Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-VEGF Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-VEGF Injection Demand (2019-2030)
2.2 World Anti-VEGF Injection Consumption by Region
2.2.1 World Anti-VEGF Injection Consumption by Region (2019-2024)
2.2.2 World Anti-VEGF Injection Consumption Forecast by Region (2025-2030)
2.3 United States Anti-VEGF Injection Consumption (2019-2030)
2.4 China Anti-VEGF Injection Consumption (2019-2030)
2.5 Europe Anti-VEGF Injection Consumption (2019-2030)
2.6 Japan Anti-VEGF Injection Consumption (2019-2030)
2.7 South Korea Anti-VEGF Injection Consumption (2019-2030)
2.8 ASEAN Anti-VEGF Injection Consumption (2019-2030)
2.9 India Anti-VEGF Injection Consumption (2019-2030)
3 WORLD ANTI-VEGF INJECTION MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Anti-VEGF Injection Production Value by Manufacturer (2019-2024)
3.2 World Anti-VEGF Injection Production by Manufacturer (2019-2024)
3.3 World Anti-VEGF Injection Average Price by Manufacturer (2019-2024)
3.4 Anti-VEGF Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Anti-VEGF Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Anti-VEGF Injection in 2023
3.5.3 Global Concentration Ratios (CR8) for Anti-VEGF Injection in 2023
3.6 Anti-VEGF Injection Market: Overall Company Footprint Analysis
3.6.1 Anti-VEGF Injection Market: Region Footprint
3.6.2 Anti-VEGF Injection Market: Company Product Type Footprint
3.6.3 Anti-VEGF Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Anti-VEGF Injection Production Value Comparison
4.1.1 United States VS China: Anti-VEGF Injection Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Anti-VEGF Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Anti-VEGF Injection Production Comparison
4.2.1 United States VS China: Anti-VEGF Injection Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Anti-VEGF Injection Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Anti-VEGF Injection Consumption Comparison
4.3.1 United States VS China: Anti-VEGF Injection Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Anti-VEGF Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Anti-VEGF Injection Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Anti-VEGF Injection Production Value (2019-2024)
4.4.3 United States Based Manufacturers Anti-VEGF Injection Production (2019-2024)
4.5 China Based Anti-VEGF Injection Manufacturers and Market Share
4.5.1 China Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Anti-VEGF Injection Production Value (2019-2024)
4.5.3 China Based Manufacturers Anti-VEGF Injection Production (2019-2024)
4.6 Rest of World Based Anti-VEGF Injection Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Anti-VEGF Injection Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Anti-VEGF Injection Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-VEGF Injection Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Ranibizumab
5.2.2 Bevacizumab
5.2.3 Aflibercept
5.2.4 Brolucizumab
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Anti-VEGF Injection Production by Type (2019-2030)
5.3.2 World Anti-VEGF Injection Production Value by Type (2019-2030)
5.3.3 World Anti-VEGF Injection Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Anti-VEGF Injection Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Age-related Macular Degeneration (AMD)
6.2.2 Diabetic Retinopathy
6.2.3 Retinal Vein Occlusion (RVO)
6.2.4 Retinopathy of Prematurity (ROP)
6.2.5 Uveitis
6.2.6 Neovascular Glaucoma
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World Anti-VEGF Injection Production by Application (2019-2030)
6.3.2 World Anti-VEGF Injection Production Value by Application (2019-2030)
6.3.3 World Anti-VEGF Injection Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Anti-VEGF Injection Product and Services
7.1.4 Roche Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Anti-VEGF Injection Product and Services
7.2.4 Bayer Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Genentech
7.3.1 Genentech Details
7.3.2 Genentech Major Business
7.3.3 Genentech Anti-VEGF Injection Product and Services
7.3.4 Genentech Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Genentech Recent Developments/Updates
7.3.6 Genentech Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Anti-VEGF Injection Product and Services
7.4.4 Novartis Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Coherus BioSciences Inc.
7.5.1 Coherus BioSciences Inc. Details
7.5.2 Coherus BioSciences Inc. Major Business
7.5.3 Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
7.5.4 Coherus BioSciences Inc. Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Coherus BioSciences Inc. Recent Developments/Updates
7.5.6 Coherus BioSciences Inc. Competitive Strengths & Weaknesses
7.6 Regeneron
7.6.1 Regeneron Details
7.6.2 Regeneron Major Business
7.6.3 Regeneron Anti-VEGF Injection Product and Services
7.6.4 Regeneron Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Regeneron Recent Developments/Updates
7.6.6 Regeneron Competitive Strengths & Weaknesses
7.7 Qilu Pharmaceutical Co.,Ltd.
7.7.1 Qilu Pharmaceutical Co.,Ltd. Details
7.7.2 Qilu Pharmaceutical Co.,Ltd. Major Business
7.7.3 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
7.7.4 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.7.6 Qilu Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.8 Innovent Biologics
7.8.1 Innovent Biologics Details
7.8.2 Innovent Biologics Major Business
7.8.3 Innovent Biologics Anti-VEGF Injection Product and Services
7.8.4 Innovent Biologics Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Innovent Biologics Recent Developments/Updates
7.8.6 Innovent Biologics Competitive Strengths & Weaknesses
7.9 Anke Biotechnology
7.9.1 Anke Biotechnology Details
7.9.2 Anke Biotechnology Major Business
7.9.3 Anke Biotechnology Anti-VEGF Injection Product and Services
7.9.4 Anke Biotechnology Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Anke Biotechnology Recent Developments/Updates
7.9.6 Anke Biotechnology Competitive Strengths & Weaknesses
7.10 Shenzhen Kangzhe Pharmaceutical Co Ltd
7.10.1 Shenzhen Kangzhe Pharmaceutical Co Ltd Details
7.10.2 Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
7.10.3 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
7.10.4 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
7.10.6 Shenzhen Kangzhe Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.11 Chengdu Kanghong Pharmaceutical Group
7.11.1 Chengdu Kanghong Pharmaceutical Group Details
7.11.2 Chengdu Kanghong Pharmaceutical Group Major Business
7.11.3 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
7.11.4 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
7.11.6 Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Anti-VEGF Injection Industry Chain
8.2 Anti-VEGF Injection Upstream Analysis
8.2.1 Anti-VEGF Injection Core Raw Materials
8.2.2 Main Manufacturers of Anti-VEGF Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Anti-VEGF Injection Production Mode
8.6 Anti-VEGF Injection Procurement Model
8.7 Anti-VEGF Injection Industry Sales Model and Sales Channels
8.7.1 Anti-VEGF Injection Sales Model
8.7.2 Anti-VEGF Injection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Anti-VEGF Injection Introduction
1.2 World Anti-VEGF Injection Supply & Forecast
1.2.1 World Anti-VEGF Injection Production Value (2019 & 2023 & 2030)
1.2.2 World Anti-VEGF Injection Production (2019-2030)
1.2.3 World Anti-VEGF Injection Pricing Trends (2019-2030)
1.3 World Anti-VEGF Injection Production by Region (Based on Production Site)
1.3.1 World Anti-VEGF Injection Production Value by Region (2019-2030)
1.3.2 World Anti-VEGF Injection Production by Region (2019-2030)
1.3.3 World Anti-VEGF Injection Average Price by Region (2019-2030)
1.3.4 North America Anti-VEGF Injection Production (2019-2030)
1.3.5 Europe Anti-VEGF Injection Production (2019-2030)
1.3.6 China Anti-VEGF Injection Production (2019-2030)
1.3.7 Japan Anti-VEGF Injection Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-VEGF Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-VEGF Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-VEGF Injection Demand (2019-2030)
2.2 World Anti-VEGF Injection Consumption by Region
2.2.1 World Anti-VEGF Injection Consumption by Region (2019-2024)
2.2.2 World Anti-VEGF Injection Consumption Forecast by Region (2025-2030)
2.3 United States Anti-VEGF Injection Consumption (2019-2030)
2.4 China Anti-VEGF Injection Consumption (2019-2030)
2.5 Europe Anti-VEGF Injection Consumption (2019-2030)
2.6 Japan Anti-VEGF Injection Consumption (2019-2030)
2.7 South Korea Anti-VEGF Injection Consumption (2019-2030)
2.8 ASEAN Anti-VEGF Injection Consumption (2019-2030)
2.9 India Anti-VEGF Injection Consumption (2019-2030)
3 WORLD ANTI-VEGF INJECTION MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Anti-VEGF Injection Production Value by Manufacturer (2019-2024)
3.2 World Anti-VEGF Injection Production by Manufacturer (2019-2024)
3.3 World Anti-VEGF Injection Average Price by Manufacturer (2019-2024)
3.4 Anti-VEGF Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Anti-VEGF Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Anti-VEGF Injection in 2023
3.5.3 Global Concentration Ratios (CR8) for Anti-VEGF Injection in 2023
3.6 Anti-VEGF Injection Market: Overall Company Footprint Analysis
3.6.1 Anti-VEGF Injection Market: Region Footprint
3.6.2 Anti-VEGF Injection Market: Company Product Type Footprint
3.6.3 Anti-VEGF Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Anti-VEGF Injection Production Value Comparison
4.1.1 United States VS China: Anti-VEGF Injection Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Anti-VEGF Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Anti-VEGF Injection Production Comparison
4.2.1 United States VS China: Anti-VEGF Injection Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Anti-VEGF Injection Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Anti-VEGF Injection Consumption Comparison
4.3.1 United States VS China: Anti-VEGF Injection Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Anti-VEGF Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Anti-VEGF Injection Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Anti-VEGF Injection Production Value (2019-2024)
4.4.3 United States Based Manufacturers Anti-VEGF Injection Production (2019-2024)
4.5 China Based Anti-VEGF Injection Manufacturers and Market Share
4.5.1 China Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Anti-VEGF Injection Production Value (2019-2024)
4.5.3 China Based Manufacturers Anti-VEGF Injection Production (2019-2024)
4.6 Rest of World Based Anti-VEGF Injection Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Anti-VEGF Injection Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Anti-VEGF Injection Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-VEGF Injection Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Ranibizumab
5.2.2 Bevacizumab
5.2.3 Aflibercept
5.2.4 Brolucizumab
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Anti-VEGF Injection Production by Type (2019-2030)
5.3.2 World Anti-VEGF Injection Production Value by Type (2019-2030)
5.3.3 World Anti-VEGF Injection Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Anti-VEGF Injection Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Age-related Macular Degeneration (AMD)
6.2.2 Diabetic Retinopathy
6.2.3 Retinal Vein Occlusion (RVO)
6.2.4 Retinopathy of Prematurity (ROP)
6.2.5 Uveitis
6.2.6 Neovascular Glaucoma
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World Anti-VEGF Injection Production by Application (2019-2030)
6.3.2 World Anti-VEGF Injection Production Value by Application (2019-2030)
6.3.3 World Anti-VEGF Injection Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Anti-VEGF Injection Product and Services
7.1.4 Roche Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Anti-VEGF Injection Product and Services
7.2.4 Bayer Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Genentech
7.3.1 Genentech Details
7.3.2 Genentech Major Business
7.3.3 Genentech Anti-VEGF Injection Product and Services
7.3.4 Genentech Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Genentech Recent Developments/Updates
7.3.6 Genentech Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Anti-VEGF Injection Product and Services
7.4.4 Novartis Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Coherus BioSciences Inc.
7.5.1 Coherus BioSciences Inc. Details
7.5.2 Coherus BioSciences Inc. Major Business
7.5.3 Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
7.5.4 Coherus BioSciences Inc. Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Coherus BioSciences Inc. Recent Developments/Updates
7.5.6 Coherus BioSciences Inc. Competitive Strengths & Weaknesses
7.6 Regeneron
7.6.1 Regeneron Details
7.6.2 Regeneron Major Business
7.6.3 Regeneron Anti-VEGF Injection Product and Services
7.6.4 Regeneron Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Regeneron Recent Developments/Updates
7.6.6 Regeneron Competitive Strengths & Weaknesses
7.7 Qilu Pharmaceutical Co.,Ltd.
7.7.1 Qilu Pharmaceutical Co.,Ltd. Details
7.7.2 Qilu Pharmaceutical Co.,Ltd. Major Business
7.7.3 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
7.7.4 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.7.6 Qilu Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.8 Innovent Biologics
7.8.1 Innovent Biologics Details
7.8.2 Innovent Biologics Major Business
7.8.3 Innovent Biologics Anti-VEGF Injection Product and Services
7.8.4 Innovent Biologics Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Innovent Biologics Recent Developments/Updates
7.8.6 Innovent Biologics Competitive Strengths & Weaknesses
7.9 Anke Biotechnology
7.9.1 Anke Biotechnology Details
7.9.2 Anke Biotechnology Major Business
7.9.3 Anke Biotechnology Anti-VEGF Injection Product and Services
7.9.4 Anke Biotechnology Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Anke Biotechnology Recent Developments/Updates
7.9.6 Anke Biotechnology Competitive Strengths & Weaknesses
7.10 Shenzhen Kangzhe Pharmaceutical Co Ltd
7.10.1 Shenzhen Kangzhe Pharmaceutical Co Ltd Details
7.10.2 Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
7.10.3 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
7.10.4 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
7.10.6 Shenzhen Kangzhe Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.11 Chengdu Kanghong Pharmaceutical Group
7.11.1 Chengdu Kanghong Pharmaceutical Group Details
7.11.2 Chengdu Kanghong Pharmaceutical Group Major Business
7.11.3 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
7.11.4 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
7.11.6 Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Anti-VEGF Injection Industry Chain
8.2 Anti-VEGF Injection Upstream Analysis
8.2.1 Anti-VEGF Injection Core Raw Materials
8.2.2 Main Manufacturers of Anti-VEGF Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Anti-VEGF Injection Production Mode
8.6 Anti-VEGF Injection Procurement Model
8.7 Anti-VEGF Injection Industry Sales Model and Sales Channels
8.7.1 Anti-VEGF Injection Sales Model
8.7.2 Anti-VEGF Injection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Anti-VEGF Injection Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Anti-VEGF Injection Production Value by Region (2019-2024) & (USD Million)
Table 3. World Anti-VEGF Injection Production Value by Region (2025-2030) & (USD Million)
Table 4. World Anti-VEGF Injection Production Value Market Share by Region (2019-2024)
Table 5. World Anti-VEGF Injection Production Value Market Share by Region (2025-2030)
Table 6. World Anti-VEGF Injection Production by Region (2019-2024) & (K Units)
Table 7. World Anti-VEGF Injection Production by Region (2025-2030) & (K Units)
Table 8. World Anti-VEGF Injection Production Market Share by Region (2019-2024)
Table 9. World Anti-VEGF Injection Production Market Share by Region (2025-2030)
Table 10. World Anti-VEGF Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Anti-VEGF Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Anti-VEGF Injection Major Market Trends
Table 13. World Anti-VEGF Injection Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Anti-VEGF Injection Consumption by Region (2019-2024) & (K Units)
Table 15. World Anti-VEGF Injection Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Anti-VEGF Injection Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Anti-VEGF Injection Producers in 2023
Table 18. World Anti-VEGF Injection Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Anti-VEGF Injection Producers in 2023
Table 20. World Anti-VEGF Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Anti-VEGF Injection Company Evaluation Quadrant
Table 22. World Anti-VEGF Injection Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Anti-VEGF Injection Production Site of Key Manufacturer
Table 24. Anti-VEGF Injection Market: Company Product Type Footprint
Table 25. Anti-VEGF Injection Market: Company Product Application Footprint
Table 26. Anti-VEGF Injection Competitive Factors
Table 27. Anti-VEGF Injection New Entrant and Capacity Expansion Plans
Table 28. Anti-VEGF Injection Mergers & Acquisitions Activity
Table 29. United States VS China Anti-VEGF Injection Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Anti-VEGF Injection Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Anti-VEGF Injection Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-VEGF Injection Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Anti-VEGF Injection Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Anti-VEGF Injection Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Anti-VEGF Injection Production Market Share (2019-2024)
Table 37. China Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-VEGF Injection Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Anti-VEGF Injection Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Anti-VEGF Injection Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Anti-VEGF Injection Production Market Share (2019-2024)
Table 42. Rest of World Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Anti-VEGF Injection Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-VEGF Injection Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Anti-VEGF Injection Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-VEGF Injection Production Market Share (2019-2024)
Table 47. World Anti-VEGF Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Anti-VEGF Injection Production by Type (2019-2024) & (K Units)
Table 49. World Anti-VEGF Injection Production by Type (2025-2030) & (K Units)
Table 50. World Anti-VEGF Injection Production Value by Type (2019-2024) & (USD Million)
Table 51. World Anti-VEGF Injection Production Value by Type (2025-2030) & (USD Million)
Table 52. World Anti-VEGF Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Anti-VEGF Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Anti-VEGF Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Anti-VEGF Injection Production by Application (2019-2024) & (K Units)
Table 56. World Anti-VEGF Injection Production by Application (2025-2030) & (K Units)
Table 57. World Anti-VEGF Injection Production Value by Application (2019-2024) & (USD Million)
Table 58. World Anti-VEGF Injection Production Value by Application (2025-2030) & (USD Million)
Table 59. World Anti-VEGF Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Anti-VEGF Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Anti-VEGF Injection Product and Services
Table 64. Roche Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Anti-VEGF Injection Product and Services
Table 70. Bayer Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Genentech Basic Information, Manufacturing Base and Competitors
Table 74. Genentech Major Business
Table 75. Genentech Anti-VEGF Injection Product and Services
Table 76. Genentech Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Genentech Recent Developments/Updates
Table 78. Genentech Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Anti-VEGF Injection Product and Services
Table 82. Novartis Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Coherus BioSciences Inc. Major Business
Table 87. Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
Table 88. Coherus BioSciences Inc. Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Coherus BioSciences Inc. Recent Developments/Updates
Table 90. Coherus BioSciences Inc. Competitive Strengths & Weaknesses
Table 91. Regeneron Basic Information, Manufacturing Base and Competitors
Table 92. Regeneron Major Business
Table 93. Regeneron Anti-VEGF Injection Product and Services
Table 94. Regeneron Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Regeneron Recent Developments/Updates
Table 96. Regeneron Competitive Strengths & Weaknesses
Table 97. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 99. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
Table 100. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 102. Qilu Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 103. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 104. Innovent Biologics Major Business
Table 105. Innovent Biologics Anti-VEGF Injection Product and Services
Table 106. Innovent Biologics Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Innovent Biologics Recent Developments/Updates
Table 108. Innovent Biologics Competitive Strengths & Weaknesses
Table 109. Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 110. Anke Biotechnology Major Business
Table 111. Anke Biotechnology Anti-VEGF Injection Product and Services
Table 112. Anke Biotechnology Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Anke Biotechnology Recent Developments/Updates
Table 114. Anke Biotechnology Competitive Strengths & Weaknesses
Table 115. Shenzhen Kangzhe Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
Table 117. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
Table 118. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
Table 120. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 121. Chengdu Kanghong Pharmaceutical Group Major Business
Table 122. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
Table 123. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Global Key Players of Anti-VEGF Injection Upstream (Raw Materials)
Table 125. Anti-VEGF Injection Typical Customers
Table 126. Anti-VEGF Injection Typical Distributors
LIST OF FIGURE
Figure 1. Anti-VEGF Injection Picture
Figure 2. World Anti-VEGF Injection Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Anti-VEGF Injection Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 5. World Anti-VEGF Injection Average Price (2019-2030) & (US$/Unit)
Figure 6. World Anti-VEGF Injection Production Value Market Share by Region (2019-2030)
Figure 7. World Anti-VEGF Injection Production Market Share by Region (2019-2030)
Figure 8. North America Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 9. Europe Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 10. China Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 11. Japan Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 12. Anti-VEGF Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 15. World Anti-VEGF Injection Consumption Market Share by Region (2019-2030)
Figure 16. United States Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 17. China Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 18. Europe Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 19. Japan Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 20. South Korea Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 22. India Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Anti-VEGF Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-VEGF Injection Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-VEGF Injection Markets in 2023
Figure 26. United States VS China: Anti-VEGF Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Anti-VEGF Injection Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Anti-VEGF Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Anti-VEGF Injection Production Market Share 2023
Figure 30. China Based Manufacturers Anti-VEGF Injection Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Anti-VEGF Injection Production Market Share 2023
Figure 32. World Anti-VEGF Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Anti-VEGF Injection Production Value Market Share by Type in 2023
Figure 34. Ranibizumab
Figure 35. Bevacizumab
Figure 36. Aflibercept
Figure 37. Brolucizumab
Figure 38. Others
Figure 39. World Anti-VEGF Injection Production Market Share by Type (2019-2030)
Figure 40. World Anti-VEGF Injection Production Value Market Share by Type (2019-2030)
Figure 41. World Anti-VEGF Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 42. World Anti-VEGF Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Anti-VEGF Injection Production Value Market Share by Application in 2023
Figure 44. Age-related Macular Degeneration (AMD)
Figure 45. Diabetic Retinopathy
Figure 46. Retinal Vein Occlusion (RVO)
Figure 47. Retinopathy of Prematurity (ROP)
Figure 48. Uveitis
Figure 49. Neovascular Glaucoma
Figure 50. Others
Figure 51. World Anti-VEGF Injection Production Market Share by Application (2019-2030)
Figure 52. World Anti-VEGF Injection Production Value Market Share by Application (2019-2030)
Figure 53. World Anti-VEGF Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 54. Anti-VEGF Injection Industry Chain
Figure 55. Anti-VEGF Injection Procurement Model
Figure 56. Anti-VEGF Injection Sales Model
Figure 57. Anti-VEGF Injection Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source
Table 1. World Anti-VEGF Injection Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Anti-VEGF Injection Production Value by Region (2019-2024) & (USD Million)
Table 3. World Anti-VEGF Injection Production Value by Region (2025-2030) & (USD Million)
Table 4. World Anti-VEGF Injection Production Value Market Share by Region (2019-2024)
Table 5. World Anti-VEGF Injection Production Value Market Share by Region (2025-2030)
Table 6. World Anti-VEGF Injection Production by Region (2019-2024) & (K Units)
Table 7. World Anti-VEGF Injection Production by Region (2025-2030) & (K Units)
Table 8. World Anti-VEGF Injection Production Market Share by Region (2019-2024)
Table 9. World Anti-VEGF Injection Production Market Share by Region (2025-2030)
Table 10. World Anti-VEGF Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Anti-VEGF Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Anti-VEGF Injection Major Market Trends
Table 13. World Anti-VEGF Injection Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Anti-VEGF Injection Consumption by Region (2019-2024) & (K Units)
Table 15. World Anti-VEGF Injection Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Anti-VEGF Injection Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Anti-VEGF Injection Producers in 2023
Table 18. World Anti-VEGF Injection Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Anti-VEGF Injection Producers in 2023
Table 20. World Anti-VEGF Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Anti-VEGF Injection Company Evaluation Quadrant
Table 22. World Anti-VEGF Injection Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Anti-VEGF Injection Production Site of Key Manufacturer
Table 24. Anti-VEGF Injection Market: Company Product Type Footprint
Table 25. Anti-VEGF Injection Market: Company Product Application Footprint
Table 26. Anti-VEGF Injection Competitive Factors
Table 27. Anti-VEGF Injection New Entrant and Capacity Expansion Plans
Table 28. Anti-VEGF Injection Mergers & Acquisitions Activity
Table 29. United States VS China Anti-VEGF Injection Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Anti-VEGF Injection Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Anti-VEGF Injection Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-VEGF Injection Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Anti-VEGF Injection Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Anti-VEGF Injection Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Anti-VEGF Injection Production Market Share (2019-2024)
Table 37. China Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-VEGF Injection Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Anti-VEGF Injection Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Anti-VEGF Injection Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Anti-VEGF Injection Production Market Share (2019-2024)
Table 42. Rest of World Based Anti-VEGF Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Anti-VEGF Injection Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-VEGF Injection Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Anti-VEGF Injection Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-VEGF Injection Production Market Share (2019-2024)
Table 47. World Anti-VEGF Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Anti-VEGF Injection Production by Type (2019-2024) & (K Units)
Table 49. World Anti-VEGF Injection Production by Type (2025-2030) & (K Units)
Table 50. World Anti-VEGF Injection Production Value by Type (2019-2024) & (USD Million)
Table 51. World Anti-VEGF Injection Production Value by Type (2025-2030) & (USD Million)
Table 52. World Anti-VEGF Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Anti-VEGF Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Anti-VEGF Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Anti-VEGF Injection Production by Application (2019-2024) & (K Units)
Table 56. World Anti-VEGF Injection Production by Application (2025-2030) & (K Units)
Table 57. World Anti-VEGF Injection Production Value by Application (2019-2024) & (USD Million)
Table 58. World Anti-VEGF Injection Production Value by Application (2025-2030) & (USD Million)
Table 59. World Anti-VEGF Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Anti-VEGF Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Anti-VEGF Injection Product and Services
Table 64. Roche Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Anti-VEGF Injection Product and Services
Table 70. Bayer Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Genentech Basic Information, Manufacturing Base and Competitors
Table 74. Genentech Major Business
Table 75. Genentech Anti-VEGF Injection Product and Services
Table 76. Genentech Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Genentech Recent Developments/Updates
Table 78. Genentech Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Anti-VEGF Injection Product and Services
Table 82. Novartis Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Coherus BioSciences Inc. Major Business
Table 87. Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
Table 88. Coherus BioSciences Inc. Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Coherus BioSciences Inc. Recent Developments/Updates
Table 90. Coherus BioSciences Inc. Competitive Strengths & Weaknesses
Table 91. Regeneron Basic Information, Manufacturing Base and Competitors
Table 92. Regeneron Major Business
Table 93. Regeneron Anti-VEGF Injection Product and Services
Table 94. Regeneron Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Regeneron Recent Developments/Updates
Table 96. Regeneron Competitive Strengths & Weaknesses
Table 97. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 99. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
Table 100. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 102. Qilu Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 103. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 104. Innovent Biologics Major Business
Table 105. Innovent Biologics Anti-VEGF Injection Product and Services
Table 106. Innovent Biologics Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Innovent Biologics Recent Developments/Updates
Table 108. Innovent Biologics Competitive Strengths & Weaknesses
Table 109. Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 110. Anke Biotechnology Major Business
Table 111. Anke Biotechnology Anti-VEGF Injection Product and Services
Table 112. Anke Biotechnology Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Anke Biotechnology Recent Developments/Updates
Table 114. Anke Biotechnology Competitive Strengths & Weaknesses
Table 115. Shenzhen Kangzhe Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
Table 117. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
Table 118. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
Table 120. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 121. Chengdu Kanghong Pharmaceutical Group Major Business
Table 122. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
Table 123. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Global Key Players of Anti-VEGF Injection Upstream (Raw Materials)
Table 125. Anti-VEGF Injection Typical Customers
Table 126. Anti-VEGF Injection Typical Distributors
LIST OF FIGURE
Figure 1. Anti-VEGF Injection Picture
Figure 2. World Anti-VEGF Injection Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Anti-VEGF Injection Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 5. World Anti-VEGF Injection Average Price (2019-2030) & (US$/Unit)
Figure 6. World Anti-VEGF Injection Production Value Market Share by Region (2019-2030)
Figure 7. World Anti-VEGF Injection Production Market Share by Region (2019-2030)
Figure 8. North America Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 9. Europe Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 10. China Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 11. Japan Anti-VEGF Injection Production (2019-2030) & (K Units)
Figure 12. Anti-VEGF Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 15. World Anti-VEGF Injection Consumption Market Share by Region (2019-2030)
Figure 16. United States Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 17. China Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 18. Europe Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 19. Japan Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 20. South Korea Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 22. India Anti-VEGF Injection Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Anti-VEGF Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-VEGF Injection Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-VEGF Injection Markets in 2023
Figure 26. United States VS China: Anti-VEGF Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Anti-VEGF Injection Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Anti-VEGF Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Anti-VEGF Injection Production Market Share 2023
Figure 30. China Based Manufacturers Anti-VEGF Injection Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Anti-VEGF Injection Production Market Share 2023
Figure 32. World Anti-VEGF Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Anti-VEGF Injection Production Value Market Share by Type in 2023
Figure 34. Ranibizumab
Figure 35. Bevacizumab
Figure 36. Aflibercept
Figure 37. Brolucizumab
Figure 38. Others
Figure 39. World Anti-VEGF Injection Production Market Share by Type (2019-2030)
Figure 40. World Anti-VEGF Injection Production Value Market Share by Type (2019-2030)
Figure 41. World Anti-VEGF Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 42. World Anti-VEGF Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Anti-VEGF Injection Production Value Market Share by Application in 2023
Figure 44. Age-related Macular Degeneration (AMD)
Figure 45. Diabetic Retinopathy
Figure 46. Retinal Vein Occlusion (RVO)
Figure 47. Retinopathy of Prematurity (ROP)
Figure 48. Uveitis
Figure 49. Neovascular Glaucoma
Figure 50. Others
Figure 51. World Anti-VEGF Injection Production Market Share by Application (2019-2030)
Figure 52. World Anti-VEGF Injection Production Value Market Share by Application (2019-2030)
Figure 53. World Anti-VEGF Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 54. Anti-VEGF Injection Industry Chain
Figure 55. Anti-VEGF Injection Procurement Model
Figure 56. Anti-VEGF Injection Sales Model
Figure 57. Anti-VEGF Injection Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source
